Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 26, 2026
The Complexity and Challenges of Translating the Dark Zone Signature into Immunohistochemistry in Diffuse Large B-Cell LymphomaShuji Momose, Keisuke Sawada, Theodora Nedeva, et al.
International Journal of Hematology|April 8, 2024
Changes in chronic myeloid leukemia treatment modalities and outcomes after introduction of second-generation tyrosine kinase inhibitors as first-line therapy: a multi-institutional retrospective study by the CML Cooperative Study GroupNoriyoshi Iriyama, Eisaku Iwanaga, Yuta Kimura, et al.
Cardio-Oncology (London, England)|July 19, 2025
The incidence of vascular adverse events and usefulness of novel risk assessment tool in Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitorsNaoki Watanabe, Tomoiku Takaku, Noriyoshi Iriyama, et al.
International Journal of Hematology|November 29, 2008
Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantationYasushi Hiramatsu, Yoshinobu Maeda, Nobuharu Fujii, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 18, 2023
[De novo blast phase of chronic myeloid leukemia with 3q26 abnormality diagnosed by cytogenetic analysis of extramedullary lesion]Takeaki Matsunaga, Ken Naganuma, Takayuki Tabayashi, et al.
International Journal of Hematology|May 2, 2023
Clinical management of second-generation tyrosine kinase inhibitor therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase, focusing on age and dose effectsMichihide Tokuhira, Yuta Kimura, Takayuki Tabayashi, et al.
International Journal of Hematology|December 13, 2025
Development of a blood test-based predictive scoring tool for treatment response in chronic myeloid leukemiaKohjin Suzuki, Tomoiku Takaku, Naoki Watanabe, et al.
Annals of Hematology|March 10, 2025
TP53 deletion is associated with poor survival of adult ALK-positive ALCL patients receiving CHOP-based chemotherapySeiichiro Katagiri, Daigo Akahane, Kunihiko Takeyama, et al.
Transplantation and Cellular Therapy|September 10, 2025
Comparison of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Primary Plasma Cell Leukemia in JapanMasaya Maegaki, Tsutomu Takahashi, Kazuhito Suzuki, et al.
Annals of Hematology|January 27, 2024
Secondary central nervous system involvement in patients with diffuse large B-cell lymphoma treated with rituximab combined CHOP therapy - a supplementary analysis of JCOG0601Kazuyuki Shimada, Ken Ohmachi, Ryunosuke Machida, et al.
Pageof 5